Source: Korea Biomedical Review

Amorepacific: Amorepacific Holdings sees strong Q1 growth driven by global rebalancing strategy

Amorepacific Holdings reported robust financial results for the first quarter of 2025, driven by the continued success of its global rebalancing strategy and strong performance across key overseas markets.The company posted consolidated sales of 1.16 trillion won ($814.8 million) and operating profi

Read full article »
Annual Revenue
$1.0-5.0B
Employees
5.0-10K
CEO Avatar

Chairman & CEO

Suh Kyung-bae

CEO Approval Rating

82/100

Read more